Sort
51,570 grants matching “autoimmune disease”
Therapeutic targeting of human islets with recombinant regulatory T cells
$709,922Seung K Kim · Stanford University · U01 · FY2022 · DK
Consequences of AhR activation in Dendritic Cells
$709,811David M Shepherd · University Of Montana · R01 · FY2017 · ES
Breathprinting as a window into gut microbiome chemoecology
$709,733Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R01 · FY2023 · HD
ROLE OF SYK PROTEIN TYROSINE KINASE IN IMMUNE FUNCTION
$709,523Washington University · P01 · FY2002 · AI
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)
$709,427Cielito C Reyes-Gibby · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Translational Vascular Biology in Autoimmune Diseases
$709,037Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P30 · FY2009 · AR
Foxp3 isoform expression and regulation of autoantibody production
$709,019Steven F Ziegler · Benaroya Research Inst At Virginia Mason · R01 · FY2025 · AI
Project 2: The Isoform repertoire and epigenome of Pediatric SLE
$708,947Jacques F Banchereau · Weill Medical Coll Of Cornell Univ · P50 · FY2017 · AR
Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease
$708,815Saumya Das · Massachusetts General Hospital · R01 · FY2025 · DK
Pathobiology of autoimmune-mediated diffuse podocytopathy
$708,681Astrid Weins · Brigham And Women'S Hospital · R01 · FY2025 · DK
A LINKAGE STUDY IN FAMILIAL PULMONARY FIBROSIS
$708,660Duke University · U01 · FY2003 · HL
Immune Response to RBC Antigens
$708,521Krystalyn E Hudson · Columbia University Health Sciences · R01 · FY2025 · HL
Studies Of Pseudohypoparathyroidism And Related Disorders
$708,430Lee Weinstein · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Identifying a novel pathway that regulates RA immunometabolism
$708,362Shiva Shahrara · University Of Illinois At Chicago · R01 · FY2022 · AI
Administrative Core
$708,360Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2023 · GM
Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes
$708,294Tracy Jennifer Doyle · Brigham And Women'S Hospital · R01 · FY2022 · HL
CCR-Frederick Flow Cytometry Core
$708,100Kathleen Noer · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS
$708,072Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2022 · DA
MAPK Signaling in Single Yeast Cells: Dynamics, Variability, and Evolution
$708,025Alexander Van Oudenaarden · Massachusetts Institute Of Technology · R01 · FY2009 · GM
Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17
$707,833Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI
Cholesterol metabolites coordinate skin barrier immunity centered on innate dermal gammadelta T cells programmed to produce IL-17
$707,833Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2019 · AI
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2022 · AI
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2020 · AI
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2021 · AI